|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
M7352
|
Genes up-regulated in HMC-1 (mast leukemia) cells: untreated versus stimulated with T cell membranes.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
6.282E-6
|
2.513E-3
|
1.651E-2
|
2.513E-3
|
3
|
200
|
2
|
M5684
|
Genes down-regulated in comparsion of ActCD8 versus ActTreg(see Fig. 1 in the paper for details).
|
MSigDB C7: Immunologic Signatures (v6.0)
|
7.236E-4
|
2.436E-2
|
1.601E-1
|
2.894E-1
|
2
|
199
|
3
|
M8859
|
Genes down-regulated in lymphoid primed multipotent progenitors versus CD4 [GeneID=920] T cells.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
7.236E-4
|
2.436E-2
|
1.601E-1
|
2.894E-1
|
2
|
199
|
4
|
M5525
|
Genes down-regulated in comparison of neutrophils versus basophils.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
7.309E-4
|
2.436E-2
|
1.601E-1
|
2.923E-1
|
2
|
200
|
5
|
M3078
|
Genes up-regulated in comparison of healthy CD4 [GeneID=920] T cells versus healthy myeloid cells.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
7.309E-4
|
2.436E-2
|
1.601E-1
|
2.923E-1
|
2
|
200
|
6
|
M3728
|
Genes up-regulated in comparison of control dendritic cells (DC) at 0 h versus those stimulated with Pam3Csk4 (TLR1/2 agonist) at 0.5 h.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
7.309E-4
|
2.436E-2
|
1.601E-1
|
2.923E-1
|
2
|
200
|
7
|
M3904
|
Genes down-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 24 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 24 h.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
7.309E-4
|
2.436E-2
|
1.601E-1
|
2.923E-1
|
2
|
200
|
8
|
M6993
|
Genes down-regulated in allogeneic T cells after stimulation with dendritic cells from: liver versus peripheral lymph nodes (pLN).
|
MSigDB C7: Immunologic Signatures (v6.0)
|
7.309E-4
|
2.436E-2
|
1.601E-1
|
2.923E-1
|
2
|
200
|
9
|
M6938
|
Genes down-regulated in B lymphocytes: CpG oligodeoxynucleotide 1826 versus PL2-3 (Chromatin IC).
|
MSigDB C7: Immunologic Signatures (v6.0)
|
7.309E-4
|
2.436E-2
|
1.601E-1
|
2.923E-1
|
2
|
200
|
10
|
M6014
|
Genes down-regulated in dendritic cells: CIITA [GeneID=4261] knockout versus I ab-/- mice.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
7.309E-4
|
2.436E-2
|
1.601E-1
|
2.923E-1
|
2
|
200
|
11
|
M6932
|
Genes down-regulated in B lymphocytes: anti IgM versus PL2-3 (Chromatin IC).
|
MSigDB C7: Immunologic Signatures (v6.0)
|
7.309E-4
|
2.436E-2
|
1.601E-1
|
2.923E-1
|
2
|
200
|
12
|
M5843
|
Genes down-regulated in comparison of virus specific (gp33) exhausted CD8 T cells versus the virus specific (gp276) cells.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
7.309E-4
|
2.436E-2
|
1.601E-1
|
2.923E-1
|
2
|
200
|
13
|
M17026
|
Genes up-regulated in three-dimentional (3D) cultures of preinvasive (S3-C) vs invasive (T4-2) breast cancer cells.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
8.053E-4
|
2.478E-2
|
1.628E-1
|
3.221E-1
|
2
|
210
|
14
|
18321301-Table2d
|
Human Stomach Galamb08 6genes
|
GeneSigDB
|
1.080E-3
|
3.086E-2
|
2.028E-1
|
4.321E-1
|
1
|
5
|
15
|
19695104-AF1-2
|
Human Breast Lin09 15genes
|
GeneSigDB
|
3.022E-3
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
14
|
16
|
M29
|
Genes whose expression positively correlated with that of SMARCA2 [GeneID=6595] in prostate cancer samples.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
3.230E-3
|
4.643E-2
|
3.050E-1
|
1.000E0
|
2
|
424
|
17
|
M3905
|
Genes down-regulated synergistically in NB4 cells (acute promyelocytic leukemia, APL) by tretinoin and NSC682994 [PubChem=444795;388304].
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
3.238E-3
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
15
|
18
|
M15150
|
Genes up-regulated in cancer stem cells isolated from mammary tumors compared to the non-tumorigenic cells.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
3.245E-3
|
4.643E-2
|
3.050E-1
|
1.000E0
|
2
|
425
|
19
|
16565969-Table1
|
Human Thyroid Stolf06 32genes
|
GeneSigDB
|
5.822E-3
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
27
|
20
|
M1500
|
Strongly down-regulated at 8-48 h during differentiation of 3T3-L1 cells (fibroblast) into adipocytes.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
6.467E-3
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
30
|
21
|
16322246-Table1
|
Mouse StemCell Poonepalli05 35genes
|
GeneSigDB
|
6.682E-3
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
31
|
22
|
M972
|
Up-regulated at 4 hours following treatment of mouse lymphocytes (TK 3.7.2C) with a high dose of methyl methanesulfonate (MMS)
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
7.756E-3
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
36
|
23
|
15608061-Table2
|
Human Breast Zucchi04 50genesup-up-regulated INV MET
|
GeneSigDB
|
8.615E-3
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
40
|
24
|
M14951
|
The 50 most up-regulated genes in primary invasive breast dutcal carcinoma (IDC) or lymph node metastases, compared to normal mammary epithelium.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
9.259E-3
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
43
|
25
|
15592497-Table3
|
Human Brain Krasnoselsky05 61genes
|
GeneSigDB
|
9.688E-3
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
45
|
26
|
M13714
|
Down-regulated genes displaying alternative splicing in MDA-MB-435 cells (breast cancer) whose metastatic potential has been reduced by expression of NME1 [GeneID=4830].
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
9.688E-3
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
45
|
27
|
M2536
|
Proteins interacting with AIRE [GeneID=326], based on massspectroscopy analysis of co-immunoprecipitates in 293T cells (embryonic kidney).
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
9.688E-3
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
45
|
28
|
M13709
|
Genes within amplicon 12q13-q21 identified in a copy number alterations study of 191 breast tumor samples.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
9.902E-3
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
46
|
29
|
M7248
|
Cluster 3: genes activated by ionizing radiation regardless of ATM [GeneID=472] status.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
1.033E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
48
|
30
|
M11458
|
Genes that comprise the proteasome gene module
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
1.055E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
49
|
31
|
M18789
|
Genes down-regulated in fibroblasts from old individuals, compared to those from young donors.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
1.204E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
56
|
32
|
16140955-Table2
|
Human Leukemia Xu05 61genes
|
GeneSigDB
|
1.247E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
58
|
33
|
11906190-Table2a-2
|
Human Colon Iizaka02 68genes
|
GeneSigDB
|
1.247E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
58
|
34
|
M1401
|
Genes whose expression in bone marrow samples correlated inversely with increased levels of serum IL5 [GeneID=3567].
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
1.376E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
64
|
35
|
M1576
|
Selected genes down-regulated during differentiation of 3T3-L1 cells (fibroblast) into adipocytes in response to adipogenic hormones.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
1.376E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
64
|
36
|
M6698
|
Up-regulated genes in metastatic vs primary solid tumors.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
1.418E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
66
|
37
|
14767473-Table2
|
Human Pancreas Nakamura04 76genes
|
GeneSigDB
|
1.440E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
67
|
38
|
19695104-AF2
|
Human Breast Lin09 128genes
|
GeneSigDB
|
1.482E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
69
|
39
|
15947096-TableS1b
|
Mouse BoneMarrow Jacquelin05 82genes
|
GeneSigDB
|
1.525E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
71
|
40
|
20035825-TableS4b
|
Mouse Lung Mikkonen10 103genes
|
GeneSigDB
|
1.610E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
75
|
41
|
17665260-Table2
|
Human Colon Kim07 95genes
|
GeneSigDB
|
1.760E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
82
|
42
|
19074895-Table3
|
Human Liver Sakai08 86genes
|
GeneSigDB
|
1.760E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
82
|
43
|
M9224
|
Selected genes up-regulated in peripheral blood monocytes (PBMC) of patients with hepatocellular carcinoma (HCC) compared to those with chronic hepatitis.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
1.781E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
83
|
44
|
20300634-T2
|
Human Breast Yoshihara10 88genes
|
GeneSigDB
|
1.824E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
85
|
45
|
12086872-Table12d
|
Human Leukemia Yeoh02 93genes
|
GeneSigDB
|
1.845E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
86
|
46
|
M1167
|
Selected genes up-regulated during progression through benign to malignant skin tumors formed by treatment with DMBA and TPA [PubChem=6001;4792] chemicals in the two stage skin carcinogenesis model.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
1.887E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
88
|
47
|
17488685-SuppTable1
|
Human Leukemia Chiaretti07 108genes
|
GeneSigDB
|
2.164E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
101
|
48
|
18304324-GeneList
|
Human Breast Xu08 112genes
|
GeneSigDB
|
2.312E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
108
|
49
|
M15305
|
Genes constituting the BRCA-centered network (BCN).
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
2.503E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
117
|
50
|
16707426-SuppTable2
|
Human Prostate Zhang06 128genes
|
GeneSigDB
|
2.609E-2
|
4.643E-2
|
3.050E-1
|
1.000E0
|
1
|
122
|